Retour
36
Également cotée sous
PHGUF
OTC
Fourchette du Jour
15,56 €
16,52 €
Fourchette 52 Semaines
7,50 €
21,34 €
Volume
73 860
Moyenne 50J / 200J
17,05 €
/
14,62 €
Clôture Précédente
16,01 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 435,2 | 0,4 |
| P/B | 4,5 | 2,9 |
| ROE % | 1,1 | 3,9 |
| Net Margin % | 0,8 | 3,8 |
| Rev Growth 5Y % | 12,7 | 10,0 |
| D/E | 0,5 | 0,2 |
Objectif de Cours des Analystes
Hold
39,50 €
+147.3%
Low: 37,00 €
High: 42,00 €
P/E Prévisionnel
95,0
BPA Prévisionnel
0,17 €
Croissance BPA (est.)
+0,0%
CA Est.
410 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,25 €
0,23 € – 0,27 €
|
600 M | 1 |
| FY2029 |
0,49 €
0,44 € – 0,53 €
|
440 M | 1 |
| FY2028 |
0,18 €
0,16 € – 0,20 €
|
350 M | 1 |
Points Clés
Revenue grew 12,73% annually over 5 years — strong growth
ROE of 1,07% is below average
Debt/Equity of 0,49 — conservative balance sheet
Generating 41,98M in free cash flow
P/E of 435,23 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,68%
Croissance
Revenue Growth (5Y)
12,73%
Revenue (1Y)8,05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
1,07%
ROIC3,52%
Net Margin0,76%
Op. Margin5,13%
Sécurité
Debt / Equity
0,49
Current Ratio2,20
Interest Coverage0,91
Valorisation
P/E Ratio
435,23
P/B Ratio4,49
EV/EBITDA63,73
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,05% | Revenue Growth (3Y) | 14,41% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12,73% | Earnings Growth (5Y) | -37,54% |
| Profitability | |||
| Revenue (TTM) | 321,12M | Net Income (TTM) | 2,43M |
| ROE | 1,07% | ROA | 0,57% |
| Gross Margin | 87,90% | Operating Margin | 5,13% |
| Net Margin | 0,76% | Free Cash Flow (TTM) | 41,98M |
| ROIC | 3,52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,49 | Current Ratio | 2,20 |
| Interest Coverage | 0,91 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 435,23 | P/B Ratio | 4,49 |
| P/S Ratio | 3,30 | PEG Ratio | -3,67 |
| EV/EBITDA | 63,73 | Dividend Yield | 0,00% |
| Market Cap | 1,06B | Enterprise Value | 1,05B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 321,12M | 297,20M | 245,32M | 205,62M | 198,87M |
| Net Income | 2,43M | -11,84M | -10,55M | 13,67M | 16,00M |
| EPS (Diluted) | 0,03 | -0,17 | -0,14 | 0,16 | 0,18 |
| Gross Profit | 282,27M | 261,80M | 220,10M | 188,06M | 177,73M |
| Operating Income | 16,49M | -8,62M | -5,39M | 18,23M | 13,56M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 425,52M | 399,99M | 462,85M | 425,80M | 397,32M |
| Total Liabilities | 189,68M | 178,92M | 244,07M | 221,16M | 204,40M |
| Shareholders' Equity | 235,84M | 221,06M | 218,78M | 204,64M | 192,92M |
| Total Debt | 115,78M | 112,31M | 171,55M | 166,69M | 161,76M |
| Cash & Equivalents | 124,32M | 54,94M | 61,74M | 207,34M | 191,92M |
| Current Assets | 254,88M | 278,44M | 316,34M | 277,50M | 249,44M |
| Current Liabilities | 115,79M | 73,80M | 77,97M | 59,70M | 46,77M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#707 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026